數學與統計
大學
求解3.79!!
點
Dofq for unilqferqgl cqses
點
Clear
Antibiotic 0 1 Total
]| 24 38 02
外 39 2 66
Total 63 65 128
Dofoq for bilqfTerql cgqses
點
Clear
Antibiotic 0 1 Total
3轉3 88
99 29 62
Total 70 02 0
Dofto for bilufTergl cqses
Clear
Antibiotic” 0) |
| | 中 88
3 3「|「遙|9@
Total 70 8$0 “150
點
Doftq for +TofTql cqses
Clear
Antibiotic 0 1 JO
1 61 89 |「150
了0作 96加|癌28
Tota] 8遇 145 278
ota呈probpbabpiltv Rule
上
圖
WP53
oking
Wek)?
oking
eek)?
oking
ek)?
who
mate
ption
ional
2N >
hose
ADBP, automated <10 寢
<10 51 還
>10 15 6
3.78 ifthe population tested is representative ofthe general
population, then what are the and Pv' using this test?
Otolaryngology
The data set in Table 3.12 is based on 214 children with
acute otitis media (otitis media with effusion or OME) who
participated in a randomized clinical trial [13]. Each child
had OME at the beginning ofthe study in either one (unilat-
eral cases) or both (bilateral cases) ears and was randomly
assigned to receive a 14-day course of one oftwo antibiot-
ics, either cefaclor (CEF) or amoxicillin (AMO). The data
here concern the 203 children whose middle-ear status
was determined during a 14-day follow-up visit. The data
20Om ll in Table 3.12 are presented in data set EAR.DAT (at www
,cengagebrain.com)-
人3 V3.79 Does there seem to be any difference in the effect of
SCN
ithe
the antibiotics on clearance of otitis media? Express your
results in terms of re/afve //sk (RAR). Consider separate
analyses for unilateral and bilateral cases. Also consider an
analysis combining the two types of cases.
3.80 The investigators recorded the ages of the children
because they felt this might be an important factor in de-
termining outcome. Were they right? Try to express your
results in terms of RR擴
3.81 While controlling for age, propose an analysis com-
paring the effectiveness ofthe two antibiotics. Express your
results in terms of AR
3.82 Another issue in this trial is the possible dependence
between ears for the bilateral cases. Comment on this issue
based on the data collected.
The concept ofarandomized clinicaltrialis discussed more
completely in Chapter 6. The analysis of contingency-table
TABLE 3.12 Format for EAR,DAT
Column 。”Variable Format or code
1-3 ID
有 人learance bv 14 daves 和1 三ves/0 二no
解答
尚無回答
您的問題解決了嗎?
看了這個問題的人
也有瀏覽這些問題喔😉
推薦筆記
經濟學-個經
857
1
經濟學-總經
773
2
微積分甲(一)
769
14
[大一微積分] Chapter2:微分學【暫停更新】
449
12
微積分(ㄧ)(二)超詳細筆記(更新)
365
1
統計學(一)
345
4
大學微積分【第零、一章】重點整理
329
6
[微積分] 積分(Integrals)
221
2
大學微積分【第二章】重點整理
199
0